Welcome to our Research Partnership Program, an initiative driven by the BINC Foundation to fuel groundbreaking advancements in the field of mother and infant health.
apply for our grantsWe are committed to fostering innovation and supporting cutting-edge projects in our four areas of expertise : mother and infant health, biotics and microbiome health, immunity and allergy, and brain devleopement.
Through our program, we offer financial support to up to five exceptional pre-clinical and clinical research projects annually, aiming to catalyze transformative discoveries that will shape the future of healthcare.
As we collaborate with passionate researchers and institutions, we envision a world where novel solutions in mother and infant health flourish, leaving a lasting positive impact on the lives of countless families.
Together, let's embark on a journey of discovery and transformation, pushing the boundaries of scientific exploration and unlocking new possibilities in the realm of maternal and infant care.
Every year, our research grants provide financial support for innovative research projects from research scientists based in universities, hospitals or leading academic institutions from all over the world.
Any clinical or preclinical research project led in the field of maternal and infant nutrition and health in one of our focused areas of expertise : mother and child nutrition, biotics and microbiome health, brain development, immunity and allergy.
BINC allocates up to 50’000 euros per research project for preclinical research and up to 100’000 euros per research project for clinical research. A bonus will be granted for publication in research journal with impact factor > 2.5
The aim is that the research will lead to a publication in a peer-reviewed Journal to diffuse the outcomes of this research to the broader scientific community.
We are thrilled to announce the opening call for grants from the Biostime Institute for Nutrition and Care (BINC), commencing in January and closing at the end of March 2024.
We are actively seeking innovative and impactful proposals in the dynamic field of maternal and child nutrition and health.
This year's grant initiative is dedicated to supporting clinical studies that contribute to advancing knowledge and improving the nutrition and health of mothers and children around three key topics.
Including attention, language & communication, social and emotional development, and cognition.
Including eczema, atopic dermatitis, allergic rhinitis, and hay-fever.
Including maternal mental health.
To apply to our Research Partnership Programme, please follow the two-steps process guidelines below.
In 2024, Biostime Institute for Nutrition & Care – the BINC Foundation has reinvigorated its funding program into Research Partnership Program. BINC has opened the call for abstract submissions in January 2024, and has just closed it by the end of March.
What is new in the 2024 BINC Research Partnership Program is the key topics for call: - Nutritional Interventions for Children's Brain Health. - (Pre-, Pro-, Post ) Biotics for allergy prevention and treatment support. - Pre & Post pregnancy health including maternal mental health.
As a global foundation, BINC-Geneva has been absolutely thrilled with the 47 high level scientific proposals received from 13 different countries. The evaluation phase of the 1st Round has been finished on the week of 8th April .
The selection process proved exceptionally challenging due to the high calibre of the proposals. Finally, 12 projects from 8 different countries were selected for the 2nd Round.
BINC extends immense gratitude to all Principal Investigators for their participation in submitting their proposals and for their keen interest in BINC 2024 Research Partnership Program.
If you’re project has been preselected at the end of the first selection round, please download and fill in the full application dossier before returning it to us by the 29th of April 2024.You will receive our final decision by the 31st of July 2024.
Conception, gestation, and lactation are critical periods for human development. The exposure to unhealthy dietary patterns, excess weight gain and other environmental factors results in a higher risk of pregnancy complications affecting both mothers and infants.
Mechanistically, inflammatory bowel diseases (IBD), principally Crohn’s disease (CD) and ulcerative colitis (UC), are considered a consequence of dysregulated interplay between host genetic-susceptibility and immunity, the enteric microenvironment, and environmental “triggers”, but the specific interactions that lead to IBD are unresolved.